Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk
Thrombosis and Haemostasis · 01.08.2025 · 125 (08) · 814-816
DOI: 10.1055/a-2544-6263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.08.2025. Verfasst von Maria Sara Mauro und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco", University of Catania, Catania, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco", University of Catania, Catania, Italy.
ORCID-Profile: Maria Sara Mauro, Davide Capodanno
Zitieren
APA
Mauro, M. S., & Capodanno, D. (2025). Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk. Thrombosis and Haemostasis, 125(08), 814-816. https://doi.org/10.1055/a-2544-6263
Vancouver
Mauro MS, Capodanno D. Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk. Thrombosis and Haemostasis. 2025;125(08):814-816. doi:10.1055/a-2544-6263
BibTeX
@article{Mauro2025,
author = {Mauro, Maria Sara and Capodanno, Davide},
title = {Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk},
journal = {Thrombosis and Haemostasis},
year = {2025},
volume = {125},
number = {08},
pages = {814--816},
doi = {10.1055/a-2544-6263}
}
EUVIMED